Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Jarecki

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Neuromuscular Diseases|February 3, 2020
Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2Jacqueline Glascock, Jacinda Sampson, Anne M Connolly, et al.
BMC Neurology|September 14, 2021
Correction to: Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers' perspective: a two-part studyTina Duong, Jessica Braid, Hannah Staunton, et al.
ACS Chemical Biology|October 9, 2008
DcpS as a therapeutic target for spinal muscular atrophyJasbir Singh, Michael Salcius, Shin-Wu Liu, et al.
Human Molecular Genetics|June 6, 2013
The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse modelsRocky G Gogliotti, Herminio Cardona, Jasbir Singh, et al.
BMC Neurology|April 1, 2021
Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers' perspective: a two-part studyTina Duong, Jessica Braid, Hannah Staunton, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Neuromuscular Diseases|February 3, 2020
Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2Jacqueline Glascock, Jacinda Sampson, Anne M Connolly, et al.
BMC Neurology|September 14, 2021
Correction to: Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers' perspective: a two-part studyTina Duong, Jessica Braid, Hannah Staunton, et al.
ACS Chemical Biology|October 9, 2008
DcpS as a therapeutic target for spinal muscular atrophyJasbir Singh, Michael Salcius, Shin-Wu Liu, et al.
Human Molecular Genetics|June 6, 2013
The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse modelsRocky G Gogliotti, Herminio Cardona, Jasbir Singh, et al.
BMC Neurology|April 1, 2021
Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers' perspective: a two-part studyTina Duong, Jessica Braid, Hannah Staunton, et al.
Pageof 4